Posts

Is Juniper Publishers Legit in 2025? A Transparent Review for Researchers

  In 2025, the academic publishing landscape continues to evolve rapidly. With the rise of open-access publishing, researchers now have more opportunities than ever to share their findings globally. Among the publishers frequently discussed in this space is Juniper Publishers — often associated with accessibility, faster publication timelines, and international reach. But an important question many researchers ask is: Is Juniper Publishers legitimate in 2025? This transparent review examines what the publisher offers, what researchers typically look for, and whether it may align with your academic publishing goals. Juniper Publishers in 2025: An Overview As of 2025, Juniper Publishers remains an active open-access academic publisher serving researchers across scientific, medical, and interdisciplinary fields. Many authors choose Juniper for several practical reasons, including: Faster editorial and peer-review timelines A user-friendly manuscript subm...
Post a Comment
Read more

How Juniper Publishers Promotes Open Science

Juniper Publishers plays a pivotal role in advancing open science by fostering accessibility, transparency, and collaboration within the global research community. Their commitment to open science is reflected through various initiatives that remove barriers to knowledge and promote the dissemination of research findings.   1. Open Access Journals One of the primary ways Juniper Publishers promotes open science is through its open-access publishing model. By offering free and unrestricted access to scientific research articles, they ensure that anyone, regardless of their location or financial resources, can access valuable scientific knowledge. This open-access approach dismantles the paywall barriers typically associated with traditional publishing, thus making research accessible to a wider audience, including researchers, students, policymakers, and the general public. 2. Encouraging Collaboration and Networking Juniper Publishers fosters an environment that encourages coll...
Post a Comment
Read more

Omega-3 Polyunsaturated Fatty Acids, Metabolic Syndrome and Diabetes Mellitus

Image
    CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL   JUNIPER PUBLISHERS Authored by Victoria Serhiyenko Abstract Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are increasingly being used to prevent cardiovascular diseases (CVD), and cardiac societies recommend the intake of 1g/day of the two ω-3 PUFAs eicosapentaenoic and docosahexaenoic acid for primary and secondary prevention of CVD. Clinical trials clearly suggest beneficial effects of ω-PUFAs consumption on lipid metabolism profile, their anti-inflammatory actions; on endothelial activation, which are likely to improve vascular function; antithrombotic and antiatherosclerotic properties. Experimental studies demonstrate direct antiarrhythmic effects, which have been challenging to document in humans. By targeting arterial stiffness and endothelial dysfunction administration of ω-3 PUFAs may prevent atherosclerosis and CVD development. A synergistic interplay showed by ω-3 PUFAs prescription suggest the potentia...
Post a Comment
Read more

Anti-hyperglycemic Effect and Regulation of Carbohydrate Metabolism by Phenolic Antioxidants of Medicinal Plants against Diabetes

Image
    CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL   JUNIPER PUBLISHERS   Authored by HP Gajera Introduction Background Diabetes mellitus is a carbohydrate metabolism disorder of endocrine system due to an absolute or relative deficiency of insulin secretion, action, or both [1]. The disorder affects more than 100 million people worldwide and it is predicted to reach 366 million by 2030. The non-insulin dependent diabetes mellitus (NIDDM, type 2) is the most prevalent form globally which is associated with elevated postprandial hyperglycemia. The occurrence of NIDDM 2 has been shown an alarming increase during the last decade (http//www.who.Int/diabetes/en/). Plant derivatives with reported hypoglycaemic properties have been used in folk medicine and traditional healing systems. Very few of these traditional antidiabetic plants have received proper scientific or medical scrutiny despite recommendations by WHO. Ayurveda and other Indian traditional approaches have...
Post a Comment
Read more

Studies on Glucagon Receptor and Antagonists of Glucagon Receptor for the Management of Diabetes Mellitus

Image
  CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL   JUNIPER PUBLISHERS Authored by Ghulam Abbas Abstract Glucagon receptor plays an important role in the glucose homeostasis and thus is drug target for the management of hyperglycemia in type-2 diabetes mellitus. The suppression of glucagon secretion from the alpha-cells is the key to control hyperglycemic condition. The identification of non-peptide antagonists of glucagon receptor is an effective therapeutic approach to inhibit the glucagon secretion to achieve normal glucose index. Keywords:  Glucagon receptor; Hyperglycemia; Diabetes mellitus; Antagonists Go to Introduction Background Diabetes mellitus is a chronic metabolic disorder which is spreading at an alarming rate all over the world. Glucagon receptor belongs to the G protein-coupled receptors (GPCRs) superfamily and an important drug target for type-2 diabetes [1]. G-Proteins (guanine nucleotide binding proteins) actually act as molecular switches to turn o...
Post a Comment
Read more

Low Grade Chronic Inflammatory Response in Pathogenicity of Diabetes Mellitus

Image
    CURRENT RESEARCH IN DIABETES & OBESITY JOURNAL   JUNIPER PUBLISHERS Authored by Shamim Shaikh Mohiuddin  Abstract Acute phase reaction which is mainly cytokine-mediated is observed to be closely involved in the pathogenesis of type 2 diabetes. Since maximum world populations are at elevated risk of developing diabetes, we tested this hypothesis by estimating circulating acute phase proteins in type 1(T-1), type 2 (T-2) diabetic patients and type 2 diabetic patients under oral hypoglycemic drugs for duration of at least 5 years. The acute phase proteins, α1- antitrypsin, α1- acid glycoprotein, ceruloplasmin and fibrinogen were estimated in the plasma in newly diagnosed 12 T-1 cases, newly diagnosed 25 T-2 cases and 25 T-2cases under oral hypoglycemic agent for at least 5 years Thirty normal controls to match the age and sex of the test groups were also studied. The levels of these proteins were correlated with their BMI and random plasma glucose values. In com...
Post a Comment
Read more